Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21057 | 1.00 | USP2 (0.61) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL28138343 | 1.00 | USP2 (0.61) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL28914 | 1.00 | USP2 (0.61) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| Ammonia Solution, Strong SCHEMBL2719059 | 0.98 | USP2 (0.59) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| Water SCHEMBL3908933 | 0.98 | USP2 (0.59) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| Sulfuric Acid SCHEMBL3238445 | 0.93 | USP2 (0.53) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| Sulfuric Acid SCHEMBL2221135 | 0.93 | USP2 (0.53) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| Phosphoric Acid SCHEMBL1696409 | 0.93 | USP2 (0.53) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| Propylamine SCHEMBL13737874 | 0.91 | USP2 (0.52) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL3504452 | 0.88 | USP2 (0.49) | USP2SLCO1B1LMNAL3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 733 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3773563-B1 | PRODRUGS OF FUSED-BICYCLIC C5AR ANTAGONISTS | CHEMOCENTRYX INC (US) | 2024-10-16 | — | — | EP | claimed |
| EP-4387647-A2 | COMPOSITIONS AND METHODS FOR TREATING RENAL DISEASES OR CONDITIONS | Acceleron Pharma Inc. (US) | 2024-06-26 | — | — | EP | claimed |
| EP-4377363-A1 | FUNCTIONALISATION OF CARBOXYMETHYLCELLULOSE | The University of Manchester (GB) | 2024-06-05 | — | — | EP | claimed |
| CN-118027177-A | Diphenyl ring Xin Guijian albumin, albumin-antineoplastic compound nano particle and its preparation method and application | 中山大学孙逸仙纪念医院 | 2024-05-14 | — | — | CN | claimed |
| EP-3728203-B1 | DIARYL SUBSTITUTED 6,5-FUSED RING COMPOUNDS AS C5aR INHIBITORS | CHEMOCENTRYX INC (US) | 2024-03-13 | — | — | EP | claimed |
| WO-2024044168-A2 | COMPOSITIONS AND METHODS FOR TREATING A V-ATPASE MALFUNCTION | LUKA SHAI THERAPEUTICS, LLC (US) | 2024-02-29 | — | — | WO | claimed |
| EP-4323512-A1 | CELLULAR PRODUCTION OF BIOPRODUCTS | Inbiose N.V. (BE) | 2024-02-21 | — | — | EP | claimed |
| EP-4323507-A2 | FERMENTATIVE PRODUCTION | Inbiose N.V. (BE) | 2024-02-21 | — | — | EP | claimed |
| EP-4323510-A1 | CELLULAR PRODUCTION OF SIALYLATED DI- AND/OR OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2024-02-21 | — | — | EP | claimed |
| EP-4298237-A1 | SINGLE CELL GLYCAN PROFILING | 10X Genomics, Inc. (US) | 2024-01-03 | — | — | EP | claimed |
| EP-1143925-A1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | Yu, Ruey J., Dr. (US) | 2001-10-17 | — | — | EP | claimed |
| WO-2000040217-B1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-10-05 | — | — | WO | claimed |
| WO-2000040217-A1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-07-13 | — | — | WO | claimed |
| EP-0859621-A1 | BIOCOMPATIBLE AQUEOUS SOLUTION FOR USE IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS | Wu, George (CA) | 1998-08-26 | — | — | EP | claimed |
| EP-0846168-A1 | NOVEL LIVER GalNAc-1-PHOSPHATE KINASE | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 1998-06-10 | — | — | EP | claimed |
| WO-1997008305-A9 | NOVEL LIVER GalNAc-1-PHOSPHATE KINASE | — | 1997-07-24 | — | — | WO | claimed |
| WO-1997008305-A1 | NOVEL LIVER GalNAc-1-PHOSPHATE KINASE | BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 1997-03-06 | — | — | WO | claimed |
| WO-1997006810-A1 | BIOCOMPATIBLE AQUEOUS SOLUTION FOR USE IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS | WU GEORGE (CA) | 1997-02-27 | — | — | WO | claimed |
| EP-0736101-A1 | ENZYMATIC METHOD FOR SYNTHESIS OF O-GLYCOSYLATED AMINO ACID OR PEPTIDE OR DERIVATIVES THEREOF | BIOFLEXIN AB (SE) | 1996-10-09 | — | — | EP | claimed |
| WO-1995018232-A1 | ENZYMATIC METHOD FOR SYNTHESIS OF O-GLYCOSYLATED AMINO ACID OR PEPTIDE OR DERIVATIVES THEREOF | BIOFLEXIN AB (SE) | 1995-07-06 | — | — | WO | claimed |